NI COVID-19 Spring Booster Programme
NI COVID-19 Booster & Flu Vaccination Programme & Vaccinator Training Resources Introduction & Key Links Welcome to the GPNI COVID-19 Booster & Flu Vaccination Programme hub – if you have feedback or...
Read MoreCategory: Prescribing Updates
Northern Ireland COVID-19 Vaccination Programme
The Department of Health Covid Vaccination Dashboard NI Covid-19 Vaccinations Dashboard Link for feedback & CPD Certificate The Green Book : Chapter 14a The coronavirus (COVID-19) vaccines The dosage and schedule for the UK...
Read MoreCOMMUNITY PHARMACY EMERGENCY SUPPLY DURING A PANDEMIC SERVICE – INFORMATION SHEET
COMMUNITY PHARMACY EMERGENCY SUPPLY DURING A PANDEMIC SERVICE – INFORMATION SHEET The Community Pharmacy Emergency Supply Service has been in operation for approximately 8 weeks. Community Pharmacists, General Practice...
Read MoreNorthern Ireland Medicines Management (June 2020)
Northern Ireland Medicines...
Read MoreDexamethasone in COVID-19
Click Here for Resource The RECOVERY trial in COVID-19 has provided initial results of the dexamethasone arm https://www.recoverytrial.net/files/recovery_dexamethasone_statement_160620_final.pdf Dexamethasone 6 mg once per day...
Read MoreWebinar – Haematology and Anticoagulation Update
Dr Gary Benson, Consultant Haematologist Belfast Trust
We are Joined by Dr Gary Benson, who will be giving us an update on changes and challenges in haematology during COVID-19 as well as a practical ‘Question and Answer session’ for members of the primary care team. Please submit any questions you would be keen for us to address with registrations.
Read MoreOral Vitamin B12 Replacement for the Treatment of Pernicious Anaemia
Oral Vitamin B12 Replacement for the Treatment of Pernicious Anaemia Many patients with pernicious anaemia are treated with lifelong intramuscular (IM) vitamin B12 replacement, the objective of this review is to provide an...
Read MoreHow to carry out a diabetic review remotely
Click Here For Resource The Primary Care Diabetes Society (PCDS) aims to support primary and community care healthcare professionals in delivering high-quality, clinically effective care in order to improve the lives of people...
Read More
POLICY FOR ASSESSMENT OF UN-USED PRESCRIBED MEDICINES FOR THE POTENTIAL TO RE-USE IN CARE HOMES (NURSING AND RESIDENTIAL CARE HOMES) AND HOSPICES –STOOD DOWN WITH EFFECT FROM 18TH MAY 2020
POLICY FOR ASSESSMENT OF UN-USED PRESCRIBED MEDICINES FOR THE POTENTIAL TO RE-USE IN CARE HOMES (NURSING AND RESIDENTIAL CARE HOMES) AND HOSPICES –STOOD DOWN WITH EFFECT FROM 18TH MAY 2020 We are continually assessing the...
Read MoreDiabetes sick day rules
i WHSCT - sick day rules i London update on Sick Days (Type 2) i TREND Type 1 Rules i TREND Type 2 Sick...
Read MoreGPNI Webinar – Diabetes and COVID-19 – 7th May 2020
Hamish Courtney Consultant Endocrinologist, RVH Louisa Dunlop Diabetic Specialist Nurse, RVH Louise Sands GPNI / NIMDTA / QUB / Sessional GP
Recorded Webinar / Slides / Feedback for appraisal certificate / Links & Resources
Read MorePCRS: Diagnosing and managing asthma attacks and people with COPD presenting in crisis during the UK Covid 19 epidemic
This pragmatic guide has been written to respond to the questions that primary care colleagues are now asking, particularly around steroid use as Covid 19 cases begin to rise. ** Updated 7th May** Diagnosing and managing asthma...
Read MoreYELLOW CARD REPORTING SITE FOR HEALTHCARE PRODUCTS USED IN CORONAVIRUS (COVID-19) – CMO / CPO
Letter from DR MICHAEL McBRIDE (Chief Medical Officer ), MRS CATHY HARRISON (Chief Pharmaceutical Officer) The Medicines and Healthcare products Regulatory Agency (MHRA) has today launched a dedicated Yellow Card reporting site...
Read MoreMHRA statement on SGLT2s during Covid
COVID-19: Use of SGLT2s in Diabetes (Dapagliflozin/Canagliflozin/Empagliflozin/Ertugliflozin The MHRA have advised that SGLT2 inhibitor treatment should be interrupted in patients who are hospitalised for majorsurgical...
Read More
